Pneumococcal Conjugate Vaccine

Resource Center

Research Summaries

PCV13 Vaccination Still Low Among Older Adults, Despite Recommendations

07/14/2017

In 2014, The Advisory Committee on Immunization Practices recommended the routine use of 13-valent pneumococcal conjugate vaccine among adults 65 years of age or older, and for it to be administered with...

07/14/2017

Research Summaries

Research Summary

CDC, AAP Release 2022-2023 Immunization Schedules for Children, Adolescents

04/04/2023

Jessica Ganga

The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.

04/04/2023

Vaccine Recommendations

ACIP Releases 2023 Adult Immunization Schedule

02/13/2023

The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.

02/13/2023

Immunization

ACIP Updates Adult Vaccine Schedule

02/22/2022

The CDC Advisory Committee on Immunization Practices recently updated their vaccine recommendations for adults.

02/22/2022

Pneumococcal Conjugate Vaccine

CDC: PCV13 No Longer Recommended for All Older Adults

11/22/2019

The Centers for Disease Control and Prevention (CDC) have released updated recommendations regarding the use of 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide...

11/22/2019

Pneumococcal Conjugate Vaccine

After PCV13, Non-Vaccine Type Pneumococcal Infections Increase Among Older Adults

06/24/2019

When PCV7 was introduced in pediatric immunization programs, adults experienced a significant decrease in pneumococcal disease. A new study evaluated the more recent introduction of the PCV13 and its impact...

06/24/2019

October 2024

Current Issue

October 2024

Volume 64

Issue 9